- Acquisition of majority in Caelo completed following antitrust clearance

- Medios becomes the market leader in Active Pharmaceutical Ingredients (APIs) for pharmacies and hospitals in Germany

- Caelo to serve as the German anchor for the European…

“We shouldn't think of diversity as a corrective measure, but as a design principle.“

Exagamglogene Autotemcel used for the first time in Germany following approval

How the disease-causing process following a Helicobacter Infection can be halted

A Charité study shows that the function of defective mucosal channels nearly returns to normal

Deadline: October 23, 2026

December 6th - December 11th, 2026

The 12-month, equity-free accelerator programsupports startups with individual coaching, practical workshops, expert knowledge, investor readiness support, and access to a strong regional and national network. A particular focus is placed on…

Klaus Rajewsky is among this year’s winners of Emory University’s Max Cooper Prize in Immunology, which recognizes scientists for their ​“transformative and revolutionary achievements.” The three winners will be formally honored on Sept. 29, 2026,…

sci2sci, a Berlin-based startup building a neurosymbolic memory layer for regulated industries, today announced it has raised €1.2 million in pre-seed funding. The round was co-led by Heliad and IBB Ventures, with participation from Robin Capital and…